Spots Global Cancer Trial Database for kidney cancer
Every month we try and update this database with for kidney cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Metastatic Kidney Cancer | NCT00004135 | Kidney Cancer Melanoma (Skin) | filgrastim therapeutic all... cyclophosphamid... fludarabine pho... peripheral bloo... | 18 Years - 65 Years | University of Chicago | |
| Sunitinib Malate in Treating Patients With Kidney Cancer | NCT00943839 | Kidney Cancer | sunitinib malat... laboratory biom... pharmacological... | 18 Years - | Centre Antoine Lacassagne | |
| Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist) | NCT04198766 | Solid Tumor Non-Small Cell ... Melanoma Head and Neck C... Gastric Cancer Renal Cell Carc... Urothelial Carc... | INBRX-106 - Hex... Pembrolizumab 2... Pembrolizumab 4... | 18 Years - | Inhibrx, Inc. | |
| Sorafenib in Treating Patients With Metastatic Kidney Cancer That Has Not Responded to Sunitinib or Bevacizumab | NCT00866320 | Kidney Cancer | sorafenib tosyl... | 18 Years - | Case Comprehensive Cancer Center | |
| A Phase I Study of Intravenous Recombinant Human IL-15 in Adults With Refractory Metastatic Malignant Melanoma and Metastatic Renal Cell Cancer | NCT01021059 | Melanoma Carcinoma, Rena... | rh IL-15 | 18 Years - 85 Years | National Institutes of Health Clinical Center (CC) | |
| Preop Laxatives in Robotic Urologic Surgery | NCT05805436 | Prostate Cancer Kidney Cancer Constipation | Polyethylene Gl... | 30 Years - 100 Years | University of Iowa | |
| OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid Tumors | NCT00471432 | Bladder Cancer Breast Cancer Kidney Cancer Lung Cancer Ovarian Cancer Prostate Cancer Unspecified Adu... | custirsen sodiu... docetaxel pharmacological... | 18 Years - 120 Years | Canadian Cancer Trials Group | |
| Avastin and Temsirolimus Following Tyrosine Kinase Inhibitor Failure in Patients With Advanced Renal Cell Carcinoma | NCT00782275 | Renal Cell Carc... Kidney Cancer | bevacizumab temsirolimus | 18 Years - | Dana-Farber Cancer Institute | |
| CARINAE for Stress Relief in Perioperative Care | NCT05184725 | Psychological S... Cardiopulmonary... Coronary Artery... Cardiac Valve R... Hip Replacement Orthognathic Su... Scoliosis Knee Replacemen... Prostate Cancer Kidney Cancer Bladder Cancer | SaMD CARINAE | 8 Years - | Adhera Health, Inc. | |
| A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886) | NCT00600496 | Breast Cancer Breast Neoplasm... Colon Cancer Colonic Cancer Colon Neoplasms Lung Cancer Melanoma Kidney Cancer | AZD6244 Dacarbazine Erlotinib Docetaxel Temsirolimus | 18 Years - 130 Years | AstraZeneca | |
| Cabozantinib for Advanced Urothelial Cancer | NCT01688999 | Urothelial Carc... Urethral Neopla... Urinary Bladder... Kidney Neoplasm... | Cabozantinib | 18 Years - 99 Years | National Institutes of Health Clinical Center (CC) | |
| Interleukin-2 in Treating Patients With Metastatic or Recurrent Kidney Cancer | NCT00002846 | Kidney Cancer | aldesleukin conventional su... | 18 Years - | National Cancer Institute (NCI) | |
| Kidney-Sparing Surgery Compared With Kidney Removal in Treating Patients With Kidney Cancer | NCT00002473 | Kidney Cancer | conventional su... | - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Random Evaluation of Patients Who Have Had Laparoscopic Partial Nephrectomy | NCT04120805 | Kidney Cancer | Hemostatic Agen... No Hemostatic A... | 18 Years - | University of Chicago | |
| Motivational Counseling in Preventing Smoking Relapse After Pregnancy in Pregnant Women Who Quit Smoking During Pregnancy | NCT00310115 | Bladder Cancer Cervical Cancer Esophageal Canc... Gastric Cancer Head and Neck C... Kidney Cancer Leukemia Liver Cancer Lung Cancer Pancreatic Canc... Tobacco Use Dis... | Smoking Prevent... Counseling Inte... Counseling Inte... | 18 Years - | M.D. Anderson Cancer Center | |
| Using Virtual Reality (VR) Models for Preoperative Planning | NCT03334344 | Kidney Cancer Renal Cell Carc... | Ceevra Reveal | 18 Years - | Ceevra, Inc. | |
| Comparison of Surgery and Active Surveillance in the Treatment of Bosniak III Renal Cysts | NCT04670887 | Cystic Renal Di... Kidney Cancer Surgery | Delayed surgery Immediate surge... | 50 Years - 75 Years | Helsinki University Central Hospital | |
| Irradiated Donor Lymphocytes in Treating Patients With Metastatic Kidney Cancer | NCT00176501 | Kidney Cancer | therapeutic all... | 18 Years - 75 Years | Rutgers, The State University of New Jersey | |
| Sunitinib Followed by Avelumab or the Reverse for Metastatic Renal Cell Carcinoma | NCT03035630 | Clear-cell Rena... RCC Kidney Cancer Clear-cell Kidn... | Avelumab Sunitinib | 18 Years - | Hoosier Cancer Research Network | |
| Interleukin-2 With or Without Histamine Dihydrochloride in Treating Patients With Metastatic Kidney Cancer | NCT00005038 | Kidney Cancer | aldesleukin histamine dihyd... | 18 Years - 75 Years | National Cancer Institute (NCI) | |
| Exhaustive Genetic and Immunological Characterization of Colon, Kidney and Liver Tumors | NCT03149523 | Colorectal Aden... Hepatic Carcino... Kidney Adenocar... | 18 Years - 80 Years | European Georges Pompidou Hospital | ||
| Renal Cancer Detection Using Convolutional Neural Networks | NCT03857373 | Kidney Cancer | - | Zealand University Hospital | ||
| A Study of Belzutifan (MK-6482) as Monotherapy and in Combination With Lenvatinib (E7080/MK-7902) With or Without Pembrolizumab (MK-3475) in China Participants With Advanced Renal Cell Carcinoma (MK-6482-010) | NCT05030506 | Renal Cell Carc... | Belzutifan Pembrolizumab Lenvatinib | 18 Years - | Merck Sharp & Dohme LLC | |
| Safety Study of Specific Tumor Target Drug Plus Immune System Therapy in Patients With Kidney Cancer | NCT00440973 | Carcinoma, Rena... | Bevacizumab Interleukin-2 | 18 Years - | The Methodist Hospital Research Institute | |
| NGR-TNF in Treating Patients With Advanced Solid Tumors | NCT00098943 | Colorectal Canc... Head and Neck C... Kidney Cancer Unspecified Adu... | CNGRC peptide-T... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Kidney Cancer | NCT03540199 | Advanced Kidney... | Activated CIK a... cryotherapy | 18 Years - 75 Years | Fuda Cancer Hospital, Guangzhou | |
| Mind-Body Health in Uro-Oncology: Research Study | NCT03852030 | Prostate Cancer Kidney Cancer Bladder Cancer | Text or email m... | 18 Years - | Northwestern University | |
| Interferon Alfa (IFN-Alpha-1b) in Renal Cancer With Metastatic Kidney Cancer | NCT00278174 | Kidney Cancer | recombinant int... | 18 Years - | Case Comprehensive Cancer Center | |
| Palbociclib and Sasanlimab for the Treatment of Advanced Clear Cell Renal Cell Carcinoma (ccRCC) or Papillary Renal Cell Carcinoma (pRCC) | NCT05665361 | Advanced Clear ... Papillary Renal... | Sasanlimab Palbocicilib | 18 Years - 100 Years | National Institutes of Health Clinical Center (CC) | |
| Biomarkers in Blood and Tumor Tissue Samples From Patients With Wilms Tumor | NCT01314391 | Kidney Cancer Renal Failure | mutation analys... polymerase chai... laboratory biom... | - 15 Years | Children's Oncology Group | |
| Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features | NCT01048892 | Adrenocortical ... Gastrointestina... Kidney Cancer Neuroblastoma Retinoblastoma Sarcoma | Seneca Valley v... cyclophosphamid... laboratory biom... pharmacological... | 3 Years - 21 Years | Children's Oncology Group | |
| Irradiated Donor Lymphocytes in Treating Patients With Metastatic Kidney Cancer | NCT00176501 | Kidney Cancer | therapeutic all... | 18 Years - 75 Years | Rutgers, The State University of New Jersey | |
| DS Titanium Ligation Clip in Urology (Prostatectomy and Nephrectomy) | NCT04869462 | Prostate Cancer Kidney Cancer Congenital Abno... Nephrolithiasis Kidney Tubercul... Nephritis Kidney Injury Hydronephrosis | 18 Years - | Aesculap AG | ||
| Gene Expression in Normal Tissue and Tumor Tissue From Patients Who Have Undergone Surgery For Kidney Cancer | NCT00899860 | Kidney Cancer | - 120 Years | Wake Forest University Health Sciences | ||
| SUTENT® In The First Line Treatment Of Renal Cell Carcinoma | NCT00460798 | Renal Cell Carc... | Sutent: observa... | - | Pfizer | |
| A Prospective Post-Market Study to Evaluate the Clinical Utility of IRIS, a Three-dimensional (3-D) Anatomical Modeling Software for Pre-operative Surgical Planning and Intra-operative Navigation for Nephrectomy | NCT04329767 | Kidney Cancer | IRIS 1.0 | 18 Years - | Intuitive Surgical | |
| Sunitinib Malate in Treating Patients With Kidney Cancer | NCT00943839 | Kidney Cancer | sunitinib malat... laboratory biom... pharmacological... | 18 Years - | Centre Antoine Lacassagne | |
| Perspective Evaluation of Hormones Involved in Serum Phosphate Homeostasis in Patients With Metastatic Renal Cells Carcinoma or Hepatocellular Carcinoma Treated With Sorafenib (SORHORM) | NCT01230697 | Kidney Cancer Liver Cancer | Sorafenib | 18 Years - | University of Turin, Italy | |
| Study of Pazopanib and Ixabepilone in Patients With Solid Tumors | NCT01012362 | Breast Cancer Lung Cancer Colon Cancer Pancreatic Canc... Head and Neck C... Kidney Cancer Sarcoma Hepatocellular ... | Pazopanib Ixabepilone | 18 Years - | Masonic Cancer Center, University of Minnesota | |
| Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma | NCT00413075 | Solid Tumor Lymphoma | oral belinostat | 18 Years - | Valerio Therapeutics | |
| Peripheral Stem Cell Transplant in Treating Patients With Metastatic Kidney Cancer | NCT00003553 | Kidney Cancer | HLA Matched Per... | 18 Years - 80 Years | National Institutes of Health Clinical Center (CC) | |
| Engagement of Patients With Advanced Cancer | NCT02966509 | End of Life Advanced Cancer Lung Neoplasm Gastric Cancer Colon Cancer Glioblastoma Mu... Head and Neck N... Rectum Cancer Melanoma Kidney Cancer Prostate Cancer Testicular Neop... Liver Cancer Cancer of Unkno... | EPAC | 18 Years - | Stanford University | |
| Tumor Collection From Routine Nephrectomy for Subjects With Advanced Stage RCC | NCT02143492 | Kidney Cancer Renal Cell Carc... Advanced Renal ... | 18 Years - | Argos Therapeutics | ||
| TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers | NCT04485013 | Cancer | TTX-080 TTX-080 pembrolizumab cetuximab | 18 Years - | Tizona Therapeutics, Inc | |
| Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy | NCT00303719 | Kidney Cancer Leukemia Lymphoma Multiple Myelom... Plasma Cell Neo... Myelodysplastic... | anti-thymocyte ... cyclophosphamid... cyclosporine fludarabine mycophenolate m... stem cell trans... total body irra... filgrastim | - 75 Years | Masonic Cancer Center, University of Minnesota | |
| Randomized Study of Sorafenib Dose Escalation in Patients With Previously Untreated Metastatic Renal Cell Carcinoma | NCT00557830 | Renal Cell Carc... | Sorafenib Escal... Sorafenib Stand... | 18 Years - | Accelerated Community Oncology Research Network | |
| Deferred Cytoreductive Nephrectomy in Synchronous Metastatic Renal Cell Carcinoma: The NORDIC-SUN-Trial | NCT03977571 | Kidney Cancer Renal Cell Carc... Synchronous Neo... | Cytoreductive n... Tissue sampling | 18 Years - | University of Aarhus | |
| Biological Therapy in Treating Patients With Metastatic Melanoma or Metastatic Kidney Cancer | NCT00020540 | Kidney Cancer Melanoma (Skin) | recombinant CD4... recombinant flt... | 16 Years - | National Cancer Institute (NCI) | |
| PS-341 in Treating Patients With Metastatic Kidney Cancer | NCT00017329 | Kidney Cancer | bortezomib | - | National Cancer Institute (NCI) | |
| Low-Intensity Stem Cell Transplantation With Multiple Lymphocyte Infusions to Treat Advanced Kidney Cancer | NCT00923845 | Renal Cell Carc... Graft-Versus-Ho... Engraftment Syn... | Pentostatin Sirolimus Cyclophosphamid... Allogeneic Hema... Th2 rapa cells Donor Lymphocyt... Induction Thera... GVHD prophylaxi... Donor Hematopoi... | 18 Years - 75 Years | National Institutes of Health Clinical Center (CC) | |
| Interleukin-2 and Pembrolizumab for Metastatic Kidney Cancer | NCT02964078 | Kidney Cancer | Pembrolizumab Interleukin-2 | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Frequency, Clinical Phenotype and Genetic Analysis of Heritable Kidney Cancer Syndromes | NCT05534854 | Renal Tumor His... Kidney Cancer Renal Cell Carc... Familial Renal ... HLRCC VHL Syndrome BAP1 Tumor Pred... FLCN Gene Mutat... ALK Gene Mutati... FH Gene Mutatio... Birt-Hogg-Dube ... MET Gene Mutati... Cutaneous Leiom... Cutaneous Leiom... | Gene test | 2 Years - | RenJi Hospital | |
| Sunitinib as First-Line Therapy in Treating Patients With Locally Advanced Metastatic Papillary Renal Cell Cancer | NCT00541008 | Kidney Cancer | sunitinib malat... | 18 Years - 120 Years | UNICANCER | |
| Monoclonal Antibody Therapy (Rencarex®) in Treating Patients Who Have Undergone Surgery for Non-metastatic Kidney Cancer | NCT00087022 | Kidney Cancer | girentuximab placebo | 18 Years - 120 Years | Heidelberg Pharma AG | |
| Study of Durvalumab and Guadecitabine in Advanced Kidney Cancer | NCT03308396 | Advanced Kidney... Kidney Cancer Clear Cell Rena... | Guadecitabine Durvalumab | 18 Years - | Big Ten Cancer Research Consortium | |
| Chemotherapy With or Without Surgery, Radiation Therapy, or Stem Cell Transplantation in Treating Young Patients With Kidney Tumors | NCT00002610 | Kidney Cancer | dactinomycin filgrastim carboplatin cyclophosphamid... doxorubicin hyd... etoposide vincristine sul... conventional su... radiation thera... | - 21 Years | Children's Oncology Group | |
| Interleukin-7 in Treating Patients With Metastatic Melanoma or Locally Advanced or Metastatic Kidney Cancer | NCT00492440 | Kidney Cancer Melanoma (Skin) | recombinant int... gene expression... polymerase chai... protein express... flow cytometry immunoenzyme te... immunologic tec... laboratory biom... pharmacological... | 18 Years - | Cytheris SA | |
| Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop Smoking | NCT00790569 | Bladder Cancer Cervical Cancer Esophageal Canc... Gastric Cancer Head and Neck C... Kidney Cancer Leukemia Liver Cancer Lung Cancer Pancreatic Canc... Tobacco Use Dis... | nicotine varenicline placebo | 18 Years - 120 Years | Butler Hospital | |
| Interleukin-12 and Interferon Alfa in Treating Patients With Metastatic Kidney Cancer or Malignant Melanoma | NCT00004244 | Kidney Cancer Melanoma (Skin) | recombinant int... recombinant int... | 18 Years - | National Cancer Institute (NCI) | |
| Monoclonal Antibody Therapy in Treating Patients With Advanced Kidney Cancer | NCT00003102 | Kidney Cancer | Iodine-131 radi... | 16 Years - | Ludwig Institute for Cancer Research | |
| Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma | NCT00002764 | Endometrial Can... Kidney Cancer Metastatic Canc... Ovarian Cancer Pheochromocytom... Sarcoma | filgrastim doxorubicin hyd... ifosfamide conventional su... | 16 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders | NCT00001238 | Kidney Cancer Urologic Malign... Renal Cell Carc... Familial Renal ... Clear Cell Rena... | 2 Years - | National Institutes of Health Clinical Center (CC) | ||
| Survivorship Promotion In Reducing IGF-1 Trial | NCT02431676 | Breast Cancer Prostate Cancer Lung Cancer Colon Cancer Melanoma of Ski... Endometrial Can... Liver Cancer Pancreatic Canc... Rectal Cancer Kidney Cancer Other Solid Mal... | Metformin Coach Directed ... Self-control we... | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Studying Biomarkers in Samples From Young Patients With Rhabdoid Tumors | NCT01544569 | Kidney Cancer | DNA analysis fluorescence in... gene expression... gene mapping microarray anal... polymerase chai... protein express... laboratory biom... medical chart r... | - 1 Year | Children's Oncology Group | |
| Chemotherapy Before and After Surgery in Treating Children With Wilm's Tumor | NCT00047138 | Kidney Cancer | dactinomycin carboplatin cyclophosphamid... doxorubicin hyd... etoposide vincristine sul... adjuvant therap... conventional su... neoadjuvant the... radiation thera... | - 18 Years | National Cancer Institute (NCI) | |
| Monoclonal Antibody Therapy (Rencarex®) in Treating Patients Who Have Undergone Surgery for Non-metastatic Kidney Cancer | NCT00087022 | Kidney Cancer | girentuximab placebo | 18 Years - 120 Years | Heidelberg Pharma AG | |
| A Phase 2 Study of the MET Kinase Inhibitor INC280 in Papillary Renal Cell Cancer | NCT02019693 | Kidney Cancer | INC280 | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Safety Study of Specific Tumor Target Drug Plus Immune System Therapy in Patients With Kidney Cancer | NCT00440973 | Carcinoma, Rena... | Bevacizumab Interleukin-2 | 18 Years - | The Methodist Hospital Research Institute | |
| High Dose IL-2 and Stereotactic Ablative Body Radiation Therapy for Metastatic Renal Cancer | NCT01896271 | Metastatic Clea... | IL-2 Stereotactic Ab... | 18 Years - 99 Years | University of Texas Southwestern Medical Center | |
| Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors | NCT03662204 | Breast Cancer Lung Cancer Colorectal Canc... Prostate Cancer Bladder Cancer Uterine Cancer Kidney Cancer Renal Pelvis Ca... Pancreatic Canc... Liver Cancer Stomach Cancer Ovarian Cancer Esophageal Canc... | Blood Sample Co... | 18 Years - | Exact Sciences Corporation | |
| Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors | NCT05704985 | Cancer Solid Tumor Colorectal Canc... Pancreas Cancer Non Small Cell ... Head and Neck C... Gynecologic Can... Skin Cancer Kidney Cancer | DK210 (EGFR) Radiation thera... Immune checkpoi... Chemotherapy | 18 Years - | DEKA Biosciences | |
| Contrast-Enhanced Ultrasound for Kidney Cancer Subtyping and Staging | NCT04021238 | Kidney Cancer | Perflutren lipi... Sulfur hexafluo... | 18 Years - 99 Years | UNC Lineberger Comprehensive Cancer Center | |
| Hereditary Leiomyomatosis Renal Cell Cancer - Study of the Genetic Cause and the Predisposition to Renal Cancer | NCT00050752 | Renal Tumor His... Cutaneous Leiom... Kidney Cancer | 2 Years - | National Institutes of Health Clinical Center (CC) | ||
| Interferon Alfa in Treating Patients With Stage IV Solid Tumors, Lymphoma, or Myeloma | NCT00276536 | Breast Cancer Kidney Cancer Lymphoma Melanoma Multiple Myelom... Sarcoma Unspecified Adu... | recombinant int... IFN | 18 Years - 120 Years | The Cleveland Clinic | |
| BMS 247550 to Treat Kidney Cancer | NCT00030992 | Renal Cell Carc... | BMS-247550 Ranitidine Diphenhydramine | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Interleukin-2 in Treating Patients With Stage III or Stage IV Kidney Cancer That Has Been Removed With Surgery | NCT00003604 | Kidney Cancer | aldesleukin | - | National Cancer Institute (NCI) | |
| Combination Chemotherapy With or Without Prednisone in Treating Patients With Recurrent and/or Metastatic Kidney Cancer | NCT00003584 | Kidney Cancer | estramustine ph... prednisone vinorelbine tar... | - 120 Years | University of New Mexico | |
| Vaccine Therapy in Treating Patients With Kidney Cancer | NCT00096629 | Kidney Cancer | human prostate-... mouse prostate-... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Cost-effectivness of Robot-assisted Surgery Compared to Open Surgery for Partial Nephrectomy in Context of Renal Tumor | NCT05089006 | Renal Tumor | Partial nephrec... | 18 Years - | Central Hospital, Nancy, France | |
| Combination of Cryosurgery and NK Immunotherapy for Advanced Kidney Cancer | NCT02843607 | Metastatic Rena... | Cryosurgery NK immunotherap... | 30 Years - 70 Years | Fuda Cancer Hospital, Guangzhou |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
